Rising Pet Ownership and Livestock Health Concerns Fuel Global Animal Vaccines Market Growth

Market.us, a leading provider of comprehensive market research, has released a detailed report on the global animal vaccines market. The report, titled “Global Animal Vaccines Market By Product, By Animal Type, By Route of Administration, and By Region – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032,” presents a thorough analysis of the market landscape, trends, and future growth prospects.

The global animal vaccines market exhibited robust growth, reaching a valuation of USD 11,657 million in 2021. With a projected compound annual growth rate (CAGR) of 8.7% from 2023 to 2032, the market is poised for significant expansion. The rising prevalence of diseases among livestock, coupled with the increasing demand for animal-derived products, is driving the adoption of vaccines worldwide.

Get Sample PDF Report: https://market.us/report/animal-vaccines-market/request-sample/

Animal Vaccines Market Key Segments

Product Analysis: Attenuated live vaccines dominated the market, accounting for a substantial revenue share in 2021. This segment is expected to maintain its dominance over the forecast period. Recombinant vaccines are projected to witness rapid growth, offering enhanced efficacy and multiple strain protection.
Animal Type Analysis: The livestock segment, including poultry, aqua, ruminants, and swine, commanded a significant revenue share in 2021. Factors such as a growing livestock population and supportive government initiatives are driving market growth. The companion animal segment is anticipated to experience accelerated growth, fueled by increasing awareness about pet health and rising pet ownership.
Route of Administration Analysis: Subcutaneous administration emerged as the dominant route in 2021, owing to its ease of use and effectiveness. However, intranasal vaccines are expected to witness the fastest growth rate during the forecast period.

By Product

Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines

By Animal type

Livestock
- Poultry
- Aqua
- Ruminants
- Swine
Companion
- Canine
- Feline
- Others

By Route of Administration

Subcutaneous
Intramuscular
Intranasal

Market Dynamics

Increasing concerns about food security, coupled with rising demand for livestock vaccines, are propelling market growth.
Technological advancements in vaccine development and the establishment of new manufacturing facilities are reshaping the market landscape.
The COVID-19 pandemic has highlighted the importance of animal health and biosecurity measures, driving investments in vaccine research and development.

Regional Analysis

North America led the market in 2021, attributed to the high prevalence of zoonotic infections and robust R&D activities. However, the Asia Pacific region is expected to witness the fastest growth, supported by increasing livestock numbers and government initiatives.

Key Regions

North America (The US, Canada, Mexico)
Western Europe (Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe)
Eastern Europe (Russia, Poland, The Czech Republic, Greece, Rest of Eastern Europe)
APAC (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC)
Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
Middle East & Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)

Buy Directly: https://market.us/purchase-report/?report_id=54840

Key Players Analysis

Merck Animal Health, a division of Merck & Co., Inc., specializes in the production of animal health solutions, including a wide range of veterinary pharmaceuticals and vaccines. The company has a strong focus on innovation and quality, supporting global animal health needs through its comprehensive product portfolio. Merck Animal Health has recently made significant strides in its commitment to global rabies eradication, supplying over five million doses of rabies vaccines through its Afya Program to target zero dog-mediated human rabies deaths by 2030. The company continues to expand its manufacturing capabilities, as demonstrated by the recent opening of a facility in the Netherlands, enhancing its production of companion animal vaccines.

Zoetis is a leading global animal health company known for its extensive range of products for animals, including vaccines and pharmaceuticals. The company’s offerings address the health needs of both livestock and companion animals. Zoetis emphasizes innovation and sustainability in its operations, aiming to improve animal health and support the veterinarians and livestock producers who depend on their products. Zoetis is recognized for its commitment to animal health and welfare, providing comprehensive solutions that enhance the productivity and well-being of animals across various sectors.

Boehringer Ingelheim is a prominent player in the veterinary vaccines market, known for its focus on providing innovative healthcare solutions. The company offers a diverse portfolio of products that cater to a wide range of animal species, including pets and livestock. Boehringer Ingelheim is committed to enhancing animal health through continuous research and development, ensuring high standards of product efficacy and safety. Their operations are guided by a commitment to improving the health of animals worldwide, with a strong emphasis on both preventive and therapeutic solutions.

Virbac positions itself as a dedicated animal health company, offering a broad spectrum of products including vaccines, pharmaceuticals, and nutritional products for pets and livestock. The company is focused on meeting the unique needs of animal health professionals, providing innovative solutions that contribute to the prevention and treatment of various animal diseases. Virbac’s commitment to research and development is evident in their proactive approach to addressing global animal health challenges, aiming to deliver practical and effective veterinary products.

Biogénesis Bagó is a South American biotechnology company specializing in the development and production of veterinary vaccines. The company has a strong emphasis on innovation and quality, catering primarily to the livestock sector. Biogénesis Bagó is recognized for its significant contributions to animal health in the region, with a robust product lineup that addresses key health issues affecting livestock. Their operations are underpinned by a deep commitment to improving animal welfare and productivity through effective disease prevention and control measures.

Animal Vaccines Market Key Players:

Merck & Co. Inc.
Zoetis
Boehringer Ingelheim International GmbH
irbac
Biogénesis Bagó
Indian Immunologicals Ltd.
Elanco
Ceva
Other Key Players

Inquire More about report: https://market.us/report/animal-vaccines-market/#inquiry

About Market.US

Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to a global clientele. Specializing in a variety of sectors, they offer strategic insights and detailed market forecasts, assisting businesses in making informed decisions. With a focus on innovation and accuracy, Market.US supports clients in over 126 countries, and maintains a strong repeat customer rate, underscoring their commitment to quality and client satisfaction. Their team excels in delivering exceptional research services, ensuring that no detail is overlooked in any target market.

Contact Details
Market.us (Powered By Prudour Pvt. Ltd.)
Contact No: +1 718 618 4351.
Email: [email protected]
Blog: https://medicalmarketreport.com/